CALIBERCOS INC-CL A (CWD) Fundamental Analysis & Valuation
NASDAQ:CWD • US13000T6047
Current stock price
1.09 USD
+0.05 (+4.81%)
At close:
1.07 USD
-0.02 (-1.83%)
After Hours:
This CWD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CWD Profitability Analysis
1.1 Basic Checks
- CWD had negative earnings in the past year.
- In the past year CWD has reported a negative cash flow from operations.
- In the past 5 years CWD reported 4 times negative net income.
- CWD had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of CWD (-16.10%) is worse than 88.70% of its industry peers.
- CWD has a Return On Equity of -1635.03%. This is amonst the worse of the industry: CWD underperforms 91.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.1% | ||
| ROE | -1635.03% | ||
| ROIC | N/A |
ROA(3y)-12.99%
ROA(5y)-7.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for CWD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. CWD Health Analysis
2.1 Basic Checks
- The number of shares outstanding for CWD has been reduced compared to 1 year ago.
- The number of shares outstanding for CWD has been reduced compared to 5 years ago.
- CWD has a better debt/assets ratio than last year.
2.2 Solvency
- CWD has an Altman-Z score of -1.19. This is a bad value and indicates that CWD is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of -1.19, CWD is not doing good in the industry: 86.61% of the companies in the same industry are doing better.
- A Debt/Equity ratio of 31.75 is on the high side and indicates that CWD has dependencies on debt financing.
- With a Debt to Equity ratio value of 31.75, CWD is not doing good in the industry: 91.63% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 31.75 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.19 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- CWD has a Current Ratio of 0.35. This is a bad value and indicates that CWD is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.35, CWD is not doing good in the industry: 80.75% of the companies in the same industry are doing better.
- A Quick Ratio of 0.35 indicates that CWD may have some problems paying its short term obligations.
- CWD has a Quick ratio of 0.35. This is amonst the worse of the industry: CWD underperforms 80.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.35 | ||
| Quick Ratio | 0.35 |
3. CWD Growth Analysis
3.1 Past
- CWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.94%, which is quite impressive.
- The Revenue for CWD has decreased by -60.69% in the past year. This is quite bad
- CWD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.93% yearly.
EPS 1Y (TTM)40.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.84%
Revenue 1Y (TTM)-60.69%
Revenue growth 3Y-37.91%
Revenue growth 5Y-11.93%
Sales Q2Q%-52.46%
3.2 Future
- The Earnings Per Share is expected to grow by 42.83% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 22.92% on average over the next years. This is a very strong growth
EPS Next Y95.34%
EPS Next 2Y42.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year26.79%
Revenue Next 2Y22.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. CWD Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CWD. In the last year negative earnings were reported.
- Also next year CWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CWD's earnings are expected to grow with 42.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.83%
EPS Next 3YN/A
5. CWD Dividend Analysis
5.1 Amount
- CWD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CWD Fundamentals: All Metrics, Ratios and Statistics
1.09
+0.05 (+4.81%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Industry Strength31.68
Industry Growth53.42
Earnings (Last)03-25 2026-03-25/amc
Earnings (Next)05-13 2026-05-13
Inst Owners2.3%
Inst Owner Change0%
Ins Owners4.52%
Ins Owner Change0%
Market Cap7.68M
Revenue(TTM)20.10M
Net Income(TTM)-21.80M
Analysts80
Price Target7.14 (555.05%)
Short Float %2.99%
Short Ratio2.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-272.44%
Min EPS beat(2)-330.07%
Max EPS beat(2)-214.8%
EPS beat(4)0
Avg EPS beat(4)-433.74%
Min EPS beat(4)-852.97%
Max EPS beat(4)-214.8%
EPS beat(8)1
Avg EPS beat(8)-459.85%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.33%
Min Revenue beat(2)-19.63%
Max Revenue beat(2)-1.03%
Revenue beat(4)1
Avg Revenue beat(4)-8.22%
Min Revenue beat(4)-19.63%
Max Revenue beat(4)3.12%
Revenue beat(8)5
Avg Revenue beat(8)30.62%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.38 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.76 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-10.63
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-1.71
FCFYN/A
OCF(TTM)-1.71
OCFYN/A
SpS2.85
BVpS0.19
TBVpS-6.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.1% | ||
| ROE | -1635.03% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-12.99%
ROA(5y)-7.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 31.75 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.35 | ||
| Quick Ratio | 0.35 | ||
| Altman-Z | -1.19 |
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.84%
EPS Next Y95.34%
EPS Next 2Y42.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-60.69%
Revenue growth 3Y-37.91%
Revenue growth 5Y-11.93%
Sales Q2Q%-52.46%
Revenue Next Year26.79%
Revenue Next 2Y22.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year602.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2273.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2273.87%
OCF growth 3YN/A
OCF growth 5YN/A
CALIBERCOS INC-CL A / CWD Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for CALIBERCOS INC-CL A?
ChartMill assigns a fundamental rating of 1 / 10 to CWD.
Can you provide the valuation status for CALIBERCOS INC-CL A?
ChartMill assigns a valuation rating of 1 / 10 to CALIBERCOS INC-CL A (CWD). This can be considered as Overvalued.
Can you provide the profitability details for CALIBERCOS INC-CL A?
CALIBERCOS INC-CL A (CWD) has a profitability rating of 0 / 10.
How financially healthy is CALIBERCOS INC-CL A?
The financial health rating of CALIBERCOS INC-CL A (CWD) is 1 / 10.